Article info
PDFColorectal
Guideline review
Guideline review: Tofacitinib for adults with moderately to severely active ulcerative colitis - NICE guidance
- Correspondence to Dr Philip J Smith, Department of Gastroenterology, Royal Liverpool and Broadgreen Hospitals NHS Trust, Liverpool, L7 8XP, UK; Philip.Smith{at}liverpoolft.nhs.uk
Citation
Guideline review: Tofacitinib for adults with moderately to severely active ulcerative colitis - NICE guidance
Publication history
- Received April 14, 2020
- Revised May 16, 2020
- Accepted May 20, 2020
- First published June 10, 2020.
Online issue publication
January 09, 2022
Article Versions
- Previous version (9 January 2022).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2021. No commercial re-use. See rights and permissions. Published by BMJ.